Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 21, 2022
Patent Application Number
16937171
Date Filed
July 23, 2020
Patent Citations Received
Patent Primary Examiner
The present invention relates to compositions, methods, and kits for eliciting an immune response to at least one CMV antigen expressed by a cancer cell, in particular for treating and preventing cancer. CMV determination methods, compositions, and kits also are provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
